Georgia's Online Cancer Information Center

Medicare now covering genetic testing

Georgia CORE

Last month, the federal government announced that Medicare has broadened its guidelines to cover USFDA-approved or -cleared genetic testing for ovarian and breast cancer patients. Genetic testing (or Next Generation Sequencing as a diagnostic laboratory test) provides the most comprehensive genetic analysis of a patient’s cancer because it enables simultaneous detection of multiple types of genetic alterations. Now more Medicare patients will have access to these tests for managing other types of inherited cancers and to reduce mortality and improve health outcomes.

“Medicare has realized that genetics is transforming medicine,” said Georgia CORE’s oncology clinical nurse specialist, Alice Kerber. “Genetic testing provides valuable information to guide patients and physicians in developing a personalized treatment plan.”

More information is at cms.gov.

Media, News & Events

Clinical Cancer Advances 2020 at a Glance

Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer highlights the most important clinical research advances of the past year and identifies priority areas where ASCO believes research efforts should be focused moving forward.

 Media & Events 2/12/2020

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.